CVS/pharmacy, the retail arm of CVS Caremark Corporation (CVS), recently operationalized a novel app that provides an unusual digital store feel for customers utilizing Apple iPads. The CVS iPad app ensures an individualized retail experience that permits shoppers to take care of their drug store requirements.
Customers may access offerings from the Photo Center, Pharmacy, ExtraCare and MinuteClinic besides navigating through a virtual 3D CVS/pharmacy. They may also browse the store for shopping.
According to the company, the CVS iPad app provides the large number of customers who check out CVS.com using a tablet with the virtual experience of visiting their local CVS/pharmacy. The app simplifies shopping and other store-related activity.
Some of the mini apps available on the CVS iPad app include the ExtraCare with Coupon Center, whereby buyers can enroll to manage their rewards and balances. The Pharmacy Services with Enhanced Prescription Management allows shoppers to quickly view their prescriptions and then decide on refills or other action. CVS/pharmacy intends to improve the CVS iPad app by integrating new add-ons that enhance virtual shopping.
On the domestic front, demographic trends, healthcare reform in the U.S., and the generic wave in the pharmaceutical industry are expected to catalyze growth for the company. In the light of these trends, CVS expects accelerating adoption of its programs such as Maintenance Choice, Pharmacy Advisor and ExtraCare loyalty program, along with expansion of its MinuteClinics.
CVS Caremark Corporation carries a Zacks Rank #2 (Buy). Drug retailers Rite Aid Corporation (RAD) and Safeway (SWY), carrying a Zacks Rank #1 (Strong Buy) are also expected to do well. Another healthcare-related stock that warrants a look is PharMerica Corporation (PMC) that carries a Zacks Rank #1 (Strong Buy).
CVS CAREMARK CP (CVS): Free Stock Analysis Report
PHARMERICA CORP (PMC): Free Stock Analysis Report
RITE AID CORP (RAD): Free Stock Analysis Report
SAFEWAY INC (SWY): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment